Avisa Pharma's Debt Round

Avisa Pharma raised a round of funding on April 22, 2016.

Avisa Pharma is a clinical stage company that is developing the first rapid, biomarker-based, point-of-care breath test for the detection of serious bacterial lung infection. Avisa's breath test techn…

Articles about Avisa Pharma's Debt Round: